Cross-linking sites of the human tau protein, probed by reactions with human transglutaminase

Journal of Neurochemistry

Volumn 71, Issue 6, 1998, Pages 2607-2614

  Murthy, S N Prasanna ^a   Wilson, James H ^a   Lukas, Thomas J ^a   Kuret, Jeff ^a   Lorand, Laszlo ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Neurofibrillary tangles; Paired helical filament; Tau protein; Transglutaminase

Indexed keywords

ARGININE; GLUTAMINE; LYSINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROFIBRILLARY TANGLE; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; PROTEIN PROCESSING;

EID: 0040041521     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71062607.x     Document Type: Article

References (48)

1. Appelt D. M. and Balin B. J. (1997) The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures. Brain Res. 745, 21-31.
2. Ballestar E., Abad C., and Franco L. (1996) Core histones are glutaminyl substrates for tissue transglutaminase. J. Biol. Chem. 271, 18817-18824.
3. Carmel G., Mager E. M., Binder L. I., and Kuret J. (1996) The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271, 32789-32795.
4. Clément S., Velasco P. T., Murthy S. N. P., Wilson J. H., Lukas T. J., Goldman R. D., and Lorand L. (1998) The intermediate filament protein, vimentin, in the lens is a target for cross-linking by transglutaminase. J. Biol. Chem. 273, 7604-7609.
5. Cleveland D. W., Hwo S. Y., and Kirschner M. W. (1977) Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116, 207-225.
6. Coussons P. J., Price N. C., Kelly S. M., Smith B., and Sawyer L. (1992) Factors that govern the specificity of transglutaminase-catalysed modification of proteins and peptides. Biochem. J. 282, 929-930.
7. Crowther R. A. (1991) Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc. Natl. Acad. Sci. USA 88, 2288-2292.
8. Crowther R. A. and Wischik C. M. (1985) Image reconstruction of the Alzheimer paired helical filament. EMBO J. 4, 3661-3665.
9. Dudek S. M. and Johnson G. V. W. (1993) Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble. Alz50-reactive polymers of τ. J. Neurochem. 61, 1159-1162.
10. Fesus L., Thomazy V., and Falus A. (1987) Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224, 104-108.
11. Folk J. E. (1983) Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation Adv. Enzymol. Relat. Areas Mol. Biol. 54, 1-56.
12. Goedert M., Spillantini M. G., Jakes R., Rutherford D., and Crowther R. A. (1989) Multiple isoforms of microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
13. Green H. (1993) Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell 74, 955-956.
14. Greenberg S. G. and Davies P. (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA 87, 5827-5831.
15. Grootjans J. J., Groenen P. J. T. A., and de Jong W. W. (1995) Substrate requirements for transglutaminases. Influence of the amino acid residue preceding the amine donor lysine in a native protein. J. Biol. Chem. 270, 22855-22858.
16. Grundke-Iqbal I., Iqbal K., Tung Y.-C., Quinlan M., Wisnewski H. M., and Binder L. I. (1986) Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83, 4913-4917.
17. Guttmann R. P., Erickson A. C., and Johnson G. V. W. (1995) τ self-association: stabilization with a chemical cross-linker and modulation by phosphorylation and oxidation state. J. Neurochem. 64, 1209-1215.
18. Johnson G. V. W., Cox T. M., Lockhart J. P., Zinnerman M. D., Miller M. L., and Powers R. E. (1997) Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res. 751, 323-329.
19. Kampers T., Friedhoff P., Biernat J., Mandelkow E.-M., and Mandelkow E. (1996) RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett. 399, 344-349.
20. Kosik K. S., Joachim C. L., and Selkoe D. J. (1986) Microtubule-associated protein τ (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA 83, 4044-4048.
21. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
22. Lee V. M.-Y., Balin B. J., Otvos L. Jr., and Trojanowski J. Q. (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251, 675-678.
23. Lorand L. (1996) Neurodegenerative diseases and transglutaminase. Proc. Natl. Acad. Sci. USA 93, 14310-14313.
24. Lorand L. and Conrad S. M. (1984) Transglutaminases. Mol. Cell. Biochem. 58, 9-35.
25. Lorand L., Rule N. G., Ong H. H., Furlanetto R., Jacobsen A., Downey J., Öner N., and Bruner-Lorand J. (1968) Amine specificity in transpeptidation. Inhibition of fibrin cross-linking. Biochemistry 7, 1214-1223.
26. Lorand L., Michalska M., Murthy S. N. P., Shohet S. B., and Wilson J. (1987) Cross-linked polymers in the red cell membranes of a patient with Hb-Koln disease. Biochem. Biophys. Res. Commun. 147, 602-607.
27. Lorand L., Parameswaran K. N., and Velasco P. T. (1991) Sorting-out of acceptor-donor relationships in the transglutaminase-catalyzed cross-linking of crystallins by the enzyme-directed labeling of potential sites. Proc. Natl. Acad. Sci. USA 88, 82-83.
28. Lorand L., Parameswaran K. N., Velasco P. T., and Murthy S. N. P. (1992a) Biotinylated peptides containing a factor XIIIa or a tissue transglutaminase-reactive glutaminyl residue that block protein cross-linking phenomena by becoming incorporated into amino donor sites. Bioconjug. Chem. 3, 37-41.
29. Lorand L., Velasco P. T., Murthy S. N. P., Wilson J., and Parameswaran K. N. (1992b) Isolation of transglutaminase-reactive sequences form complex biological systems: a prominent lysine donor sequence in bovine lens. Proc. Natl. Acad. Sci. USA 89, 11161-11163.
30. Miller C. C. J. and Anderton B. H. (1986) Transglutaminase and the neuronal cytoskeleton in Alzheimer's disease. J. Neurochem. 46, 1912-1922.
31. Miller M. L. and Johnson G. V. W. (1995) Transglutaminase cross-linking of the τ protein. J. Neurochem. 65, 1760-1770.
32. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Titani K., and Ihara Y. (1995) Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270, 823-829.
33. Murthy S. N. P., Wilson J., Zhang Y., and Lorand L. (1994) Residue Gln-30 of human erythrocyte anion transporter is a prime site for reaction with intrinsic transglutaminase. J. Biol. Chem. 269, 22907-22911.
34. Murthy S. N. P., Velasco P. T., and Lorand L. (1998a) Properties of purified lens transglutaminase and regulation of its transamidase/crosslinking activity by GTP. Exp. Eye Res. 66, 531-536.
35. Murthy S. N. P., Wilson J., Lukas T., and Lorand L. ( 1998b) How do transglutaminases select the reactive lysine residues in their protein substrates? FASEB J. 12, A1432.
36. Parameswaran K. N., Velasco P. T., Wilson J., and Lorand L. (1990) Labeling of ∈-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. Proc. Natl. Acad. Sci. USA 87, 8472-8475.
37. Paudel H. K. (1997) Phosphorylation by neuronal cdc2-like protein kinase promotes dimerization of tau protein in vitro. J. Biol. Chem. 272, 28328-28334.
38. Radek J. T., Jeong J.-M., Murthy S. N. P., Ingham K. C., and Lorand L. (1993) Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin. Proc. Natl. Acad. Sci. USA 90, 3152-3156.
39. a. J. Biol. Chem. 270, 21827-21832.
40. Schweers O., Schonbrunn-Hanebeck E., Marx A., and Mandelkow E. (1994) Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J. Biol. Chem. 269, 24290-24297.
41. Selkoe D. J., Abraham C., and Ihara Y. (1982) Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers. Proc. Natl. Acad. Sci. USA 79, 6070-6074.
42. 2+-induced cross-linking of membrane proteins in intact human erythrocytes. Biochemistry 17, 2598-2604.
43. Smith M. A., Taneda S., Richey P. L., Miyata S., Van S.-D., Stern D., Sayre L. M., Monnier V. M., and Perry G. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 91, 5710-5714.
44. Wang P. C., Vancura A., Mitcheson T. G. M., and Kuret J. (1992) Two genes in Saccharomyces cerevisiae encode a membrane-bound form of casein kinase-1. Mol. Biol. Cell 3, 275-286.
45. Wille H., Drewes G., Biernat J., Mandelkow E.-M., and Mandelkow E. (1992) Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J. Cell Biol. 118, 573-584.
46. Wischik C. M., Novak M., Thogersen H. C., Edwards P. C., Runswick M. J., Jakes R., Walker J. E., Milstein C., Roth M., and Klug A. (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA 85, 4506-4510.
47. Wisniewski H. M. and Wegiel J. (1995) The neuropathology of Alzheimer's disease. Neuroimaging Clin. N. Am. 5, 45-57.
48. Wood J. G., Mirra S. S., Pollock N. J., and Binder L. I. (1986) Neurofibrillary tangles of Alzheimer disease share antigenic determinants with axonal microtubule-associated protein τ (tau). Proc. Natl. Acad. Sci. USA 83, 4040-4043.